Skip to content

Faculty profile

Deepali Kumar

Back to faculty
ResearcherInfectious DiseasesUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026

  • Innovation in active and passive immunisation of people who are immunocompromised: a call to action.

    The Lancet. Infectious diseases · 2026

  • Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026

All 175 publications

Latest funding

  • Planning a national approach to infectious disease and vaccine surveillance in transplantation

    CIHR · 2025 · Co-investigator

    $25,000
  • Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial): SAFETY AND IMMUNOGENICITY OF PANDEMIC INFLUENZA VACCINE IN KIDNEY TRANSPLANT RECIPIENTS

    CIHR · 2024 · Principal investigator

    $149,674
  • SAFE LUNG: Short-course Antiviral and Focused Exposure to UV light in LUNG transplantation to prevent transmission of hepatitis B virus from donor organs.

    CIHR · 2024 · Principal investigator

    $199,065
All 11 grants and awards
Something wrong or missing on this profile? Suggest a correction